Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Jad M Abdelsattar, M.D, FACS

Breast Surgical Onc · University of Oxford

View

Dr. Lauren Kopicky

Breast Surgical Onc · Cleveland Clinic

View

Dr. Jennifer Plichta

Breast Surgical Onc · Duke University

View

Dr. Sarah Blair

Breast Surgical Onc · UCSD

View

Dr. Karen Goodwin

Breast Surgical Onc · UCSF

View

Dr. Christin Collins

Breast Surgical Onc · MetroHealth

View

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Todd Rosengart

Cardiac Surgery · BCM

View

Dr. Larry Kaiser

Thoracic Surgery · UPenn

View

Dr. Neri Cohen

Thoracic Surgery · XVIVO

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Utility of Surgical Axillary Staging in Microinvasive Ductal Carcinoma In Situ: A National Cancer Database Analysis.

    Apr 9, 2025DOI: 10.1245/s10434-024-16727-2Journal ArticleASO

    Written by: Christian X LavaVarsha HarishKelly KappKaren R LiAustin D WilliamsNathan WongSami FerdousianCarmen De CarvajalAshwini ParanjpeIan T GreenwaltJennifer D SonKenneth L FanLucy M De La Cruz

    Find these authors on Roon

    AW

    Dr. Austin Williams

    Breast Surgical Onc · Fox Chase Cancer Center

    JS

    Dr. Jennifer Son

    Breast Surgical Onc · Medstar Montgomery Medical Center

    Summary

    BACKGROUND: Surgical axillary staging (ASx) of patients with microinvasive ductal carcinoma in situ (cT1mi) is debated due to the low occurrence of nodal metastasis. This study aimed to assess the utility of surgical axillary staging for clinically node-negative (cN0) T1mi breast cancer patients.METHODS: This retrospective cohort study analyzed data from the National Cancer Database (NCDB) to investigate the axillary status of patients with cT1mi breast cancer between 2012 and 2019. Patient demographics, clinical characteristics, treatment methods, and pathologic findings were collected.RESULTS: Of 10,843 patients, 9220 (85%) underwent ASx, whereas 1623 (15%) did not. Of the 4190 patients who underwent mastectomy, 244 (6%) did not undergo ASx, whereas 3946 (94%) did, 373 (9%) of whom were pN+. Of the 9069 patients who underwent ASx and had known nodal status, 8512 (94%) were pN- and 557 (6%) were pN+. The factors independently associated with increased odds of having positive nodes were younger age (odds ratio [OR], 1.02; 95% confidence interval [CI], 1.01-1.03; p < 0.001), black race (OR, 1.51; 95% CI, 1.12-2.10; p = 0.007), lymphovascular invasion (OR, 13.72; 95% CI, 10.25-18.36; p < 0.001), and mastectomy (OR, 1.98; 95% CI, 1.57-2.51; p < 0.001). Among the pN+ patients, only 64 (1%) had ≥3 positive nodes and would require axillary lymph node dissection (ALND).CONCLUSION: Surgical axillary staging is commonly performed for patients with cT1mi breast cancer despite the pN- status of most and the disproportionate morbidity associated with ASx. Identifying factors that predict a higher likelihood of pN+ status could allow for personalized surgical approaches, reducing unnecessary ASx for many patients.
    JSDr. Jennifer Son

    Dr. Jennifer Son

    Surgery · Breast Surgical Oncology
    Medstar Montgomery Medical Center
    jenniferson